# OnCo record dronabinol (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dronabinol/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dronabinol" ;
  schema:name "Dronabinol"@en ;
  schema:alternateName "Synthetic THC"@en, "Delta-9-tetrahydrocannabinol"@en, "Marinol / Syndros" ;
  schema:description "Dronabinol is synthetic THC in a capsule, approved in 1985 for chemotherapy nausea and vomiting that other antiemetics have failed to control, and later for appetite loss in AIDS; it sits well behind the 5-HT3 and NK1 antagonists in today's guidelines."@en ;
  schema:url <https://onco.cc/drugs/dronabinol/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Dronabinol> ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018651>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=dronabinol>, <https://en.wikipedia.org/wiki/Dronabinol> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Oral small-molecule synthetic cannabinoid" ;
  onco:approval "US 1985: Nausea and vomiting from cancer chemotherapy in patients who have failed conventional antiemetics" ;
  onco:targets <https://onco.cc/targets/cnr1/> ;
  onco:companies <https://onco.cc/companies/abbvie/>, <https://onco.cc/companies/insys-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06731894/> .